Browse Articles

Discover research articles across all indexed journals

Divergent long-term burden trajectories and mortality drivers of female-specific cancers in the United States.

Journal of Clinical Oncology Ze Jin Jul 01, 2026 DOI: 10.1200/jco.2026.44.19_suppl.203

203 Background: Female-specific cancers contribute substantially to the cancer burden among women in the United States, yet comparative long-term assessments of burden trajectories and mortality drivers remain limited. Methods: Using Global Burden of Disease data (1990–2023), we conducted a population-based longitudinal analysis of breast, cervical, ovarian, and uterine cancers among U.S. females, assessing prevalence, incidence, mortality, and disability. Temporal trends were evaluated using estimated annual percentage change (EAPC) overall, by period and age group, and logarithmic decomposition of mortality into incidence and mortality-to-incidence ratios (MIR) components. Results: From 1990 to 2023, age-standardized incidence and mortality rates increased for uterine cancer (incidence EAPC, 1.67% [95% CI, 1.58–1.76]; mortality EAPC, 1.01% [0.82–1.20]), whereas both incidence and mortality declined for breast, cervical, and ovarian cancers. Specifically, incidence EAPCs were −1.16% (−1.25 to −1.06) for breast cancer, −1.67% (−1.94 to −1.40) for cervical cancer, and −1.43% (−1.60 to −1.27) for ovarian cancer; corresponding mortality EAPCs were −1.64% (−1.72 to −1.57), −0.99% (−1.09 to −0.89), and −1.39% (−1.55 to −1.22), respectively. Decomposition analysis showed that rising incidence accounted for 181% of the uterine cancer mortality increase, whereas incidence reductions explained 63%, 158%, and 98% of the mortality decreases in breast, cervical, and ovarian cancers, respectively, with MIR changes contributing the remainder. Conclusions: Female-specific cancers in U.S. exhibit heterogeneous trends, with uterine cancer mortality driven by rising incidence and declining mortality from other female cancers largely reflecting incidence reductions, underscoring uterine cancer as an emerging priority for prevention and early detection.

Prognostic role of mismatch repair status in stage II colon cancer at Ho Chi Minh City Oncology Hospital.

Journal of Clinical Oncology Quy Nguyen, Duc Phan Thi Hong, Nhu Ngoc Nguyen Pham Jul 01, 2026 DOI: 10.1200/jco.2026.44.19_suppl.146

146 Background: Colon cancer is among the leading causes of cancer incidence and mortality in Vietnam according to GLOBOCAN 2022. In stage II colon cancer, mismatch repair (MMR) status determined by immunohistochemistry is an important biomarker for prognostic assessment and selection of patients who may benefit from adjuvant chemotherapy. Methods: A retrospective descriptive study was conducted in 185 patients with stage II colon cancer treated at Ho Chi Minh City Oncology Hospital between January 1, 2017 and December 31, 2020. MMR status was evaluated by immunohistochemistry. Five-year disease-free survival (DFS) and overall survival (OS) were analyzed according to MMR status. Multivariate Cox regression was performed to identify prognostic factors. Results: Deficient MMR (dMMR) was identified in 33% of patients and proficient MMR (pMMR) in 67%. Among dMMR tumors, concurrent loss of MLH1/PMS2 and MSH2/MSH6 expression were the most frequent patterns (42.6% and 31.2%, respectively). The 5-year DFS rate was 97.8% in the dMMR group and 82.2% in the pMMR group (p=0.005). The 5-year OS rate was 97.9% and 87.2%, respectively (p=0.132). The liver was the most common metastatic site in the pMMR group. On multivariate analysis, dMMR status was associated with DFS (HR=0.109, p=0.033), while bowel obstruction was associated with OS (HR=3.652, p=0.028). Conclusions: MMR status is an independent prognostic factor in stage II colon cancer. Patients with dMMR tumors demonstrate superior disease-free survival compared with those with pMMR, supporting the clinical relevance of routine MMR assessment in this population.

Toughening elastomer via sequentially activated multi-pathway energy dissipation

Nature Communications Xue Li, Chunlin Xiao, Haruki Izutsu et al. Jul 01, 2026 DOI: 10.1038/s41467-026-74148-z

Abstract Auxiliary energy dissipation pathways have been incorporated into elastomer design to enhance the toughness. However, most strategies involving multiple pathways rely on non-synergistic dissipation that ceases to function once structural evolution occurs. Herein, we report a strategy to toughen elastomer via sequentially activated multi-pathway energy dissipation, simultaneously integrating mechanically interlocked networks (MINs), scissile mechanophore, and woven networks within a single polymer. A rotaxane crosslinker is applied to construct MINs in polyurethane as the primary energy dissipation pathway. After the sliding motion of the rotaxane crosslinkers reaches its maximal extent, the truxinate mechanophore embedded in rotaxane’s macrocycle undergoes sacrificial scission as the secondary pathway. Subsequently, the linear chain produced by cleavage of the rotaxane’s macrocycle inherently entangles with the axle chain, resulting in woven networks as the tertiary energy dissipation pathway. This strategy substantially enhances the toughness and clarifies how mechanophore activation interacts with supramolecular architecture in polymeric materials.

Discovery, Genome-Guided Structure Elucidation, and Total Synthesis of Terukufazoline A, a Macrocyclic Docosapeptide, from a Marine Cyanobacterium

Journal of the American Chemical Society Raimu Taguchi, Akira Ebihara, Yuta Tsunematsu et al. Jul 01, 2026 DOI: 10.1021/jacs.6c06625

Y-maze performance predicts refined motor learning in mice

PLoS ONE Isak Karlsson, Thawann Malfatti, Klas Kullander et al. Jul 01, 2026 DOI: 10.1371/journal.pone.0352676

The relationships between distinct abilities and their interdependencies during memory tasks and motor learning activities are not clear. An important question is whether being proficient in memory or motor learning tasks also translates into better performance in another, similar task – reflecting potential generalization of motor learning abilities. To investigate the correlation between memory performance and motor learning, we used a combination of behavioral tasks that assess general exploratory behavior, declarative memory, and fine motor learning in female mice. For the exploratory behavior, we used the open field task, and assessed declarative memory using the novel object recognition and Y-maze. Motor performance and learning was assessed through the vertical pole and pellet reaching tasks. We found a positive correlation between the Y-maze and the pellet reaching task performance, where a higher exploration rate indicated a higher success ratio in the pellet reaching task. Further, leave-one-out cross-validation prediction analysis show that Y-maze performance is a robust predictor of pellet reaching performance, showing that mice pellet reaching performance can reliably be predicted from Y-maze performance. These results can be used to conduct a pre-study for challenging motor tasks that include pre-behavioral procedures on mice. Our study shows that performance in the Y-maze predicts pellet reaching performance, indicating that these tasks can be used as pre-screening for motor learning performance and activity.

Taxonomic profiling of nematode community using morphological and metabarcoding approaches under diverse irrigation systems

Scientific Reports Vyshali Gandhi, Sandip Mondal, Vishal Singh Somvanshi et al. Jul 01, 2026 DOI: 10.1038/s41598-026-60057-0

Soft, Degradable, and Magnetic Microcarriers for Encapsulation and Guided Transport of Drugs and 3D Spheroids

Advanced Materials Xuan Peng, Lulu Song, Daryna Mruga et al. Jul 01, 2026 DOI: 10.1002/adma.73735

ABSTRACT Soft microcarriers hold great potential for biomedical applications, yet their translation is limited by the lack of controlled degradation, restricted capacity for co‐encapsulation of therapeutic and cellular cargos, long‐term biocompatibility, and scalable production challenges. Here, we introduce a new concept of discrete, degradable hydrogel microcarriers, produced via droplet‐based microfluidics and UV photopolymerization, designed to integrate these properties. These soft microcarriers enable co‐encapsulation of multiple species, including magnetic particles, drugs, and living cell spheroids, while allowing precise motion control over complex trajectories using external gradient magnetic fields. Their tunable degradation under physiological conditions ensures transient stability, controlled navigation, and safe clearance. This approach provides spatiotemporal control over cargo transport and release, enabling the microcarriers to function as systems with a controllable lifecycle. These multifunctional microcarriers represent a versatile platform for tissue engineering, minimally invasive therapies, and diagnostic monitoring, enhanced by the precise in situ navigation option.

Intracellular lactic acidosis reprograms glycolysis and mitochondrial anaplerosis in cancer cells

Journal of Biological Chemistry Chengmeng Jin, Siying Zeng, Hao Wu et al. Jul 01, 2026 DOI: 10.1016/j.jbc.2026.113150

When the Nose Knows: Canine Olfaction and the Emerging Paradigm of Multicancer Detection

Journal of Clinical Oncology Shiran Shapira, Nadir Arber Jul 01, 2026 DOI: 10.1200/jco-26-00688

Targeted and immunotherapy strategies in biliary tract cancer: A Bayesian network meta-analysis comparing efficacy and safety.

Journal of Clinical Oncology Siti Nurluthfia Rachmi, Damien Basukresna, Leonardo Kevin Senjaya Jul 01, 2026 DOI: 10.1200/jco.2026.44.19_suppl.141

141 Background: Biliary tract cancer is an aggressive malignancy with limited treatment options and poor prognosis. Advances in targeted therapy and immune checkpoint inhibition have expanded systemic treatment strategies, yet comparative evidence remains limited. This study aimed to evaluate and compare the efficacy and safety of VEGFR inhibitors, FGFR inhibitors, IDH1 inhibitors, PD-1/PD-L1 inhibitors, chemotherapy, and placebo. The primary objective was to rank treatments based on objective response rate (ORR), while the secondary objective assessed safety using adverse event (AE) outcomes. Methods: Randomized controlled trials were systematically identified. A Bayesian network meta-analysis was conducted using MetaInsight. Treatment effects were estimated using pooled odds ratios with Markov chain Monte Carlo simulations. Ranking probabilities and surface under the cumulative ranking curve (SUCRA) values were calculated to compare efficacy (ORR) and safety (adverse events) across treatments. Results: For efficacy, VEGFR inhibitors ranked highest (SUCRA 92.10), followed by FGFR inhibitors (74.92) and cisplatin plus gemcitabine (55.35). PD-1/PD-L1 inhibitors (19.24) and placebo (8.39) demonstrated lower ORR rankings. VEGFR inhibitors had the greatest probability of being best (82%), while FGFR inhibitors most frequently ranked second (70%). For safety, VEGFR inhibitors also ranked highest (SUCRA 95.31), followed by IDH1 inhibitors (54.98), PD-1/PD-L1 inhibitors (34.40), and placebo (15.31). VEGFR inhibitors showed a 90% probability of being safest. These findings suggest that VEGFR-targeted therapy provides a favorable balance between efficacy and safety. FGFR inhibitors also demonstrated strong efficacy performance, while IDH1 inhibitors showed moderate safety advantages. PD-1/PD-L1 inhibitors exhibited comparatively lower efficacy with intermediate safety. Despite heterogeneity across studies, consistent SUCRA trends support robustness of the results. Conclusions: VEGFR inhibitors demonstrate the most favorable balance of efficacy and safety, followed by FGFR inhibitors in efficacy and IDH1 inhibitors in safety. These findings provide comparative evidence to support treatment selection in biliary tract cancer, although further direct head-to-head trials are warranted to confirm these results.

Transposable elements impact the human regulatory landscape through cell type specific epigenomic associations

Nature Communications Jeffrey Hyacinthe, Guillaume Bourque Jul 01, 2026 DOI: 10.1038/s41467-026-74920-1

Two of a Kind: Composition and Photophysics of Two Silver Nanoclusters Stabilized by the Same DNA Sequence

Journal of the American Chemical Society Letizia Liccardo, Hiroki Kanazawa, Giacomo Romolini et al. Jul 01, 2026 DOI: 10.1021/jacs.6c04812

Reliability of cancer screening questions from the National Health Interview Survey

PLoS ONE Larry G. Kessler, Bryan Comstock, Erin J. Aiello Bowles et al. Jul 01, 2026 DOI: 10.1371/journal.pone.0352356

Background The National Health Interview Survey (NHIS), a nationwide in-person and telephone survey of the civilian non-institutionalized population, is used to measure progress towards Healthy People objectives on cancer screening. Survey reports have been compared to medical record data to assess validity of these questions; however, few studies have assessed reliability, or response consistency over time. We assessed the test-retest reliability of questions on cervical, colorectal, breast and lung cancer screening from the 2021 and 2022 NHIS. Methods We surveyed 1,770 adults ages 18 + years with and without prior screening for breast, cervical, colorectal, and lung cancer from four U.S. health systems (three in Washington state and one in Michigan) to examine validity of the NHIS questions. Among people who completed the validity survey, we randomized individuals to receive an additional survey one month later (N = 944) and three months later (N = 822). We calculated Cohen’s Kappa, Gwet’s AC1, and simple concordance to assess reliability. Results Among our study sample, 535 (56.7% of those assigned) to one month follow-up and 537 (65.0%) assigned to three month follow-up completed the reliability survey. Among these, 36 (6.6%) and 94 (17.6%) of those assigned to one and three month follow-up respectively were excluded from reliability analyses because they had additional screening tests after completing the validity survey. Cohen’s Kappa showed strong-to-moderate reliability for being up to date with mammography screening: 0.83 at one month and 0.78 at three months; reliability for other screening tests was considerably lower: 0.61 and 0.60 for cervical, 0.57 and 0.62 for colorectal, and 0.72 and 0.58 for lung and one and three months, respectively. Conclusions We found strong-to-moderate reliability of responses recalling breast cancer screening at one and three months following an initial survey. Reliability may not be a major threat to self-reported cancer screening behavior.

Toward Multi(radio)metalated DNA: Enzymatic Polymerization of Metal‐Chelate‐Modified Deoxyribonucleoside Triphosphates

Angewandte Chemie International Edition Antonio A. W. L. Wong, François Bénard, David M. Perrin Jul 01, 2026 DOI: 10.1002/anie.1429706

ABSTRACT We report the first enzymatic synthesis of precisely defined metal‐oligonucleotide conjugates through template‐directed polymerase‐mediated primer extension with two different (radio)metal‐chelator‐modified deoxyribonucleoside triphosphates. We successfully incorporated five different metals (Ga, In, Tb, Lu, and Y) along designed oligonucleotide templates, including the simultaneous incorporation of two different metal chelates within a given strand. To provide bio‐orthogonality, this approach exploits the well‐known enzymatic fidelity of DNA polymerase to generate uniformly metal‐loaded DNA constructs with well‐defined and programmable compositions. The platform is validated using chelators DOTA and DTPA and confirmed by both inductively coupled plasma mass spectrometry (ICP‐MS) quantification and autoradiographic analysis following gel electrophoresis to demonstrate radioisotope incorporation with clinically relevant metals ( 68 Ga for PET, 111 In for SPECT, 161 Tb and 177 Lu for β − therapy), establishing the potential for using the information content of DNA to create multi‐metalated radiopharmaceuticals. This programmable platform establishes a new paradigm for metalated molecular probe development with versatility for potential therapeutic, theranostic, and mass spectrometry‐based applications, and potentially generalizable to other metal isotopes based on diagnostic or therapeutic requirements.

Fluorite and rare-metals mineralization in greisenized granite of Um Naggat area, Egypt constrained by physical separation and beneficiation assessment

Scientific Reports Mona M. Fawzy, Mohamed Diab, Ahmed E. Abdel Gawad Jul 01, 2026 DOI: 10.1038/s41598-026-58961-6

Abstract Fluorite and rare-metals mineralization hosted within the greisenized granites of Um Naggat area, Central Eastern Desert, Egypt, represents a potential source of critical raw materials. The studied sample is dominated by quartz and feldspar, with a minor heavy-mineral fraction enriched in fluorite and accessory rare-metal phases, including zircon, columbite, ilmenite, cassiterite, uranothorite, monazite, aegirine, almandine garnet, iron oxides, and biotite. Comprehensive mineralogical, geochemical, and beneficiation investigations were conducted to assess the recovery potential of fluorite and associated rare-metals mineralization. Particle-size analysis and mineralogical characterization indicated favorable liberation of the target minerals, enabling efficient separation from the silicate gangue. Gravity concentration using a Wilfley shaking table upgraded the total heavy-mineral (THM) content from 1.95 wt% in the feed to 6.11 wt% in the combined concentrate, achieving an overall THM recovery of ~ 80%. Subsequent high-intensity magnetic separation effectively partitioned the concentrate into fluorite-rich diamagnetic and rare-metals-bearing magnetic fractions. XRD and SEM-EDS analyses indicate that fluorite is the dominant phase in the diamagnetic product, accompanied by accessory zircon and galena, while columbite, thorite, garnet, and other rare-metals-bearing minerals are concentrated in the magnetic fraction. The results demonstrate the effectiveness of a combined gravity–magnetic beneficiation flowsheet for upgrading fluorite and associated rare-metals mineralization from the studied greisenized granite under laboratory-scale conditions. These findings provide a basis for further process optimization and detailed technical and economic evaluation of Um Naggat mineralization.

The expanding role of formulations to enable oral delivery of poorly water-soluble drugs

Nature Reviews Drug Discovery Keisuke Ueda, Christopher J. H. Porter, Aaron Goodwin et al. Jul 01, 2026 DOI: 10.1038/s41573-026-01407-5

Dynamic Organic–Inorganic Interpenetrating Nanonetwork for Stiff and Durable Flexible Material

Advanced Materials Yan He, Weifeng Fang, Kai Yin et al. Jul 01, 2026 DOI: 10.1002/adma.73753

ABSTRACT The longstanding trade‐off between stiffness and durable flexibility has limited the performance envelope of structural materials, constraining their application in demanding engineering fields. Here, we reveal an alternative organic–inorganic hybrid architecture to integrate these contradictory properties. Inspired by interpenetrating polymer networks, we interpenetrate an inorganic nanonetwork into the organic network via polymerization of inorganic ionic oligomers. In this way, an organic–inorganic (bacterial cellulose‐calcium phosphate) interpenetrating nanonetwork was constructed, and notably, a dynamically reversible inter‐network bonding was discovered under external force. This dynamic organic–inorganic interpenetrating nanonetwork (DIN) leads to a composite material with both high stiffness and high energy dissipation ability during deformation, exhibiting metal‐like bending rigidity while sustaining 20 000 bending cycles without fatigue fracture. This demonstrates a resolution to stiffness and durable flexibility integration in structural materials. Moreover, the DIN structure exhibits resistance to harsh environments, including extreme temperatures (−196°C to 200°C) and high humidity (90% RH). Combined with its lightweight, electromagnetic transparency, and naturally derived components, DIN‐based composites represent promising candidates for next‐generation stiff yet durable flexible protective structural materials. This work extends the polymer‐inspired approach to synthesize non‐classical inorganic structures, while broadening the understanding of organic–inorganic composite architectures in integrating distinct material properties.

Kindlin-3 sustains cytokine interleukin-2 signaling by linking its receptor to integrin LFA-1

Journal of Biological Chemistry Zheng-Kai Teng, Neeru Arya, Yinghui Li et al. Jul 01, 2026 DOI: 10.1016/j.jbc.2026.113159

Germline landscape of pancreatic cancer in Singapore and dual architecture of DNA repair and pancreatitis-associated gene variants: Implications for population-tailored testing.

Journal of Clinical Oncology Nur Diana Ishak, Suat Ying Lee, Zewen Zhang et al. Jul 01, 2026 DOI: 10.1200/jco.2026.44.19_suppl.162

162 Background: Germline pathogenic/likely pathogenic (P/LP) variants occur in up to 10% of pancreatic cancer (PC) patients, predominantly in DNA damage repair (DDR) genes, and increasingly guide therapeutic decisions including PARP inhibitor eligibility. However, germline data derive almost exclusively from European-ancestry cohorts, leaving a critical gap in Asian populations where PC incidence is rising. We characterised the prevalence, spectrum and clinical correlates of germline P/LP variants in a multi-ethnic Singapore PC cohort. Methods: We retrospectively reviewed 398 consecutive PC patients referred to the Cancer Genetics Service, National Cancer Centre Singapore (2014-2025); 332 (83.4%) underwent multigene germline panel testing. Variant distribution was assessed across functional gene categories and ethnicities. Pancreatitis-genotype correlations were evaluated among pancreatitis-gene carriers. Case-control enrichment analyses compared allele frequencies against 9,702 ancestry-matched controls from the Singapore 10K Genome Project using Fisher’s exact test with Benjamini-Hochberg correction. Results: Germline P/LP variants were identified in 64/332 tested patients (19.3%) across 18 genes, revealing two predominant functional categories: DDR genes (50.0% of carriers; ATM 17.2%, BRCA2 10.9%, PALB2 7.8%, BRCA1 4.7%) and pancreatitis-associated genes (45.3%; CFTR 29.7%, SPINK1 12.5%, PRSS1 3.1%). CFTR was the single most frequently mutated gene. P/LP carriers were younger at diagnosis (mean 59.8 vs 62.5 years), with the highest detection rate in patients <50 years (40.0%). Among pancreatitis-gene carriers, documented pancreatitis occurred in 37.5% of CFTR and 28.6% of SPINK1 carriers despite ascertainment limited to clinically apparent episodes. Case-control analysis confirmed significant enrichment for ATM, BRCA2 , and MLH1 variants (q<0.05), with suggestive enrichment for CFTR . Eighty-one percent of DDR carriers harboured PARP inhibitor-eligible gene variants, representing ~10% of all tested patients. Conclusions: This first Southeast Asian PC germline study reveals a dual genetic architecture-DDR and pancreatitis-associated pathways-distinct from Western cohorts where BRCA2 predominates. The prominence of CFTR , SPINK1 and PRSS1, comprising nearly half of all findings, demands that germline panels for Asian patients include pancreatitis-associated genes to avoid missing ~45% of actionable variants. These findings support universal germline testing, a dual-surveillance paradigm integrating cancer-focused and inflammation-directed monitoring, and provide population-specific evidence to inform testing strategies and guideline development for Asian populations.

Cancer mortality rates by educational attainment among U.S. adults aged 25–64 years: A population-based analysis (2021–2023).

Journal of Clinical Oncology Mohammad Soomro, Hala Soomro, Zafar Aleem Suchal Jul 01, 2026 DOI: 10.1200/jco.2026.44.19_suppl.348

348 Background: Educational attainment is a key social determinant of health that may influence cancer outcomes through differences in prevention, early detection, treatment access, and health literacy. Contemporary population-based estimates of education-related cancer mortality gradients remain limited. Methods: We performed a population-based cross-sectional analysis using CDC WONDER Multiple Cause of Death data (2021–2023). Cancer deaths were identified using ICD-10 malignant neoplasm codes (C00–C97). Population denominators were derived from American Community Survey (ACS) B15001 1-year estimates pooled across 2021–2023. Mortality rates were calculated within age bands (25–34, 35–44, 45–64) and age-standardized within ages 25–64 using pooled ACS age distribution weights. Analyses were stratified by sex and educational attainment. Results: A strong inverse gradient between educational attainment and cancer mortality was observed in both sexes. Among females, age-adjusted mortality ranged from 45.4 per 100,000 among individuals with graduate/professional degrees to 133.7 per 100,000 among those without a high school diploma. Among males, rates ranged from 36.2 to 163.1 per 100,000 across the same educational extremes. The mortality rate ratio comparing lowest versus highest educational attainment was 2.9 among females and 4.5 among males. Intermediate educational categories demonstrated stepwise increases in mortality, indicating a continuous gradient rather than a threshold effect. Disparities were more pronounced among males and were driven by mortality in the 45–64 age group. Conclusions: Educational attainment is strongly associated with cancer mortality among working-age U.S. adults, with consistent gradients across education levels. These findings demonstrate reproducible education-based cancer mortality disparities using population denominators and highlight structural inequities representing critical targets for cancer prevention and control strategies. Age-adjusted cancer mortality rates by educational attainment among US adults aged 25–64 years, 2021–2023. Educational attainment (ACS) Female AAMR per 100,000 Female RR vs Grad/Prof Male AAMR per 100,000 Male RR vs Grad/Prof Graduate or professional degree (ref) 45.4 1.00 36.2 1.00 Bachelor’s degree 60.3 1.33 49.6 1.37 Some college, no degree 67.0 1.48 64.0 1.77 Associate’s degree 86.7 1.91 77.2 2.13 High school graduate (incl equivalency) 140.0 3.08 145.0 4.01 9th–12th grade, no diploma 133.7 2.95 163.1 4.50 AAMR indicates age-adjusted mortality rate per 100,000; ACS, American Community Survey. Mortality counts derived from CDC WONDER (Multiple Cause of Death). Population denominators obtained from ACS B15001 (1-year) and pooled across 2021–2023. Age adjustment performed across three age bands (25–34, 35–44, 45–64). Estimates represent national population rates.